---
title: "Vyne Therapeutics set for 1-for-50 reverse stock split on July 24"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293666112.md"
description: "Vyne Therapeutics announced a 1-for-50 reverse stock split effective July 24. Shares will trade on a split-adjusted basis on Nasdaq starting July 27 under CUSIP 92941V407. This move coincides with the company's target to close its proposed merger with Yarrow by early week July 27, pending Nasdaq listing clearance."
datetime: "2026-07-23T20:50:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293666112.md)
  - [en](https://longbridge.com/en/news/293666112.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293666112.md)
generator: "portal-rs"
---

# Vyne Therapeutics set for 1-for-50 reverse stock split on July 24

-   Vyne Therapeutics plans a 1-for-50 reverse stock split effective July 24. \* Shares are set to trade on a split-adjusted basis on Nasdaq from July 27 under CUSIP 92941V407. \* The split comes as the company targets an early-week July 27 close for its proposed merger with Yarrow, pending Nasdaq listing clearance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyne Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607231626PRIMZONEFULLFEED9767426) on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [VYNE.US](https://longbridge.com/en/quote/VYNE.US.md)
- [YARW.US](https://longbridge.com/en/quote/YARW.US.md)

## Related News & Research

- [Yarrow Bioscience files amended 8-K report on merger exchange ratio update](https://longbridge.com/en/news/295840217.md)
- [Vyne Therapeutics announces special shareholder meeting on proposed Yarrow merger](https://longbridge.com/en/news/292318015.md)
- [Annita Tanini Sells 1,224 Shares of Keros Therapeutics (NASDAQ:KROS) Stock](https://longbridge.com/en/news/296537997.md)
- [Chevron Chief Legal Officer R. Hewitt Pate reports CVX share disposal worth $506,620.74](https://longbridge.com/en/news/296535421.md)
- [AIIR: H1'26 saw resilient revenue and stable Adjusted EBITDA amid disruption, with growth set to accelerate](https://longbridge.com/en/news/296476265.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**